QS Research · Michael Burry's Scion Capital analyst template · 2006
METTLER TOLEDO INTERNATIONAL INC/ (MTD)
As of 2026-11-17 · 12/15 boxes filled from SEC filings and market data
Report price $1,727.26 (close 2026-11-16); latest close $1,666.88 (2026-11-20), -3.5% since the report; figures re-marked at the latest close
Conclusion: PASS
Conviction medium · base case -6% · downside -28% · upside +17%
The business is high quality — 45.8% ROIC against an 8.2% WACC, a 20.7% FCF margin — but at $1,727.26 the market already pays for it: 36.8x TTM earnings, 28.4x EV/EBITDA, and a reverse DCF that needs +12.5% revenue growth a year for ten years against +4.0% in the latest fiscal year. Nothing in the news flow explains the price; the multiple does. That is why the call is PASS — the quality is real, but the entry price leaves no margin of safety. The cases bracket the outcome: the downside is $1,199.69, -30.5%, on -10.0% earnings at a compressed P/E of 28.4x (today 36.8x); the base is $1,572.37, -9.0%, on a P/E at 33.5x, the peer median P/E; the upside is $1,951.80, +13.0%, on +13% earnings at today's P/E of 36.8x. The distribution is skewed against the buyer: the largest move on the board is the downside, and the upside is the smallest.
Key numbers
- Share price: $1,666.88
- Market cap: $33.15B
- Latest financial period: TTM to Sep 30, 2026
- Revenue (TTM): $4.20B
- EV / EBITDA (TTM): 27.5x
- P/E (TTM): 35.5x
- FCF yield: 2.6%
- Price / book: 426.92x
- Earnings-quality flags (TTM): none flagged
- EV / FCF (TTM): 40.3x
- Revenue growth (latest fiscal year): +4.0%
- ROIC (TTM): 45.8%
- WACC: 8.2%
- Economic profit spread: +37.6 pts
The 15 boxes
- ✓ 1. Long-form business notes
MTD is a global precision-instrument maker selling lab instruments (~56% of FY2025 net sales), industrial instruments (~39%) and retail weighing (~5%), through five reportable segments and a ~9,300-person sales and service organization in ~40 countries. Its history shows steady scale-up with a sharp margin of resilience: revenue went $3.09B (FY2020) to $4.03B (FY2025) and $4.20B on a TTM basis to Sep 2026, while net income went $602.7M to $869.2M to $934.1M over the same spans, with only FY2023 showing a dip. The mix has drifted toward the Americas (42% of FY2025 net sales vs 38% in FY2020) and toward lab instruments and service (service 25% of FY2025 net sales vs 23% in FY2023). Capital return, not operations, drives the balance sheet: buybacks of $775.0M to $1.10B a year took total equity from $282.7M (FY2020) to -$23.6M (FY2025), only partly recovered to $77.7M at the TTM date.
- ✓ 2. Competitive advantage
The filings claim a real competitive moat — worldwide market leadership, global brand, innovation track record, a large installed base, and diversification — and the numbers are consistent with it: gross profit grew from $1.80B (FY2020) to $2.39B (FY2025) and $2.54B (TTM to 2026-09-30) as revenue went from $3.09B to $4.03B to $4.20B, with no visible gross-margin erosion, while operating cash flow ($955.8M FY2025, $984.4M TTM) exceeds net income ($869.2M, $934.1M) on capex of only $107.1M and $113.8M. But the 10-K itself calls the markets "highly competitive" and fragmented, with regional, larger-parent and lower-cost emerging-market rivals, and states these forces "can impair our operating margins." The moat is thus pricing power and installed-base/service lock-in rather than an uncontested market; China (16% of 2025 external sales, 29% of segment profit, ~29% of production) and tariff costs (~$50M in 2025) are the main pressure points on it.
- ✓ 3. 10-Q takeaways
Q3 2026 sales rose 6% reported and in local currency to $1.094B, with Asia/Rest of World local currency +14%; gross margin was 59.8% and adjusted operating profit $333.5M. GAAP diluted EPS was $12.29 and adjusted EPS $12.57; nine-month figures include a one-time net tariff-refund benefit that should be kept out of operating trends. Management guides Q4 2026 local currency sales +~5% and adjusted EPS $14.84-$15.04, and FY2026 adjusted EPS $47.70-$47.90. The 10-Q reports no material risk-factor changes.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.